These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 36116454)
1. Single CT colonography versus three rounds of faecal immunochemical test for population-based screening of colorectal cancer (SAVE): a randomised controlled trial. Sali L; Ventura L; Mascalchi M; Falchini M; Mallardi B; Carozzi F; Milani S; Zappa M; Grazzini G; Mantellini P Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):1016-1023. PubMed ID: 36116454 [TBL] [Abstract][Full Text] [Related]
2. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study. Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734 [TBL] [Abstract][Full Text] [Related]
3. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Stoop EM; de Haan MC; de Wijkerslooth TR; Bossuyt PM; van Ballegooijen M; Nio CY; van de Vijver MJ; Biermann K; Thomeer M; van Leerdam ME; Fockens P; Stoker J; Kuipers EJ; Dekker E Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831 [TBL] [Abstract][Full Text] [Related]
4. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R; Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893 [TBL] [Abstract][Full Text] [Related]
5. Reduced and Full-Preparation CT Colonography, Fecal Immunochemical Test, and Colonoscopy for Population Screening of Colorectal Cancer: A Randomized Trial. Sali L; Mascalchi M; Falchini M; Ventura L; Carozzi F; Castiglione G; Delsanto S; Mallardi B; Mantellini P; Milani S; Zappa M; Grazzini G; J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26719225 [TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357 [TBL] [Abstract][Full Text] [Related]
7. Faecal immunochemical test in subjects not attending screening computed tomography colonography and colonoscopy in a randomized trial. Sali L; Ventura L; Mascalchi M; Falchini M; Mantellini P; Delsanto S; Milani S; Zappa M; Grazzini G Eur J Cancer Prev; 2018 Mar; 27(2):105-109. PubMed ID: 27428397 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening. Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575 [TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study). Sali L; Grazzini G; Carozzi F; Castiglione G; Falchini M; Mallardi B; Mantellini P; Ventura L; Regge D; Zappa M; Mascalchi M; Milani S Trials; 2013 Mar; 14():74. PubMed ID: 23497601 [TBL] [Abstract][Full Text] [Related]
10. Colon capsule endoscopy versus CT colonography in FIT-positive colorectal cancer screening subjects: a prospective randomised trial-the VICOCA study. González-Suárez B; Pagés M; Araujo IK; Romero C; Rodríguez de Miguel C; Ayuso JR; Pozo À; Vila-Casadesús M; Serradesanferm A; Ginès À; Fernández-Esparrach G; Pellisé M; López-Cerón M; Flores D; Córdova H; Sendino O; Grau J; Llach J; Serra-Burriel M; Cárdenas A; Balaguer F; Castells A BMC Med; 2020 Sep; 18(1):255. PubMed ID: 32943059 [TBL] [Abstract][Full Text] [Related]
11. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. de Wijkerslooth TR; de Haan MC; Stoop EM; Bossuyt PM; Thomeer M; Essink-Bot ML; van Leerdam ME; Fockens P; Kuipers EJ; Stoker J; Dekker E Gut; 2012 Nov; 61(11):1552-9. PubMed ID: 22198714 [TBL] [Abstract][Full Text] [Related]
12. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme. de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962 [TBL] [Abstract][Full Text] [Related]
13. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test. Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260 [TBL] [Abstract][Full Text] [Related]
14. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening. Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mundt MW; Spijker WJ; Bongers EJC; Kuipers EJ; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905 [TBL] [Abstract][Full Text] [Related]
15. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population]. Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312 [No Abstract] [Full Text] [Related]
16. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex? Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I; BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318 [TBL] [Abstract][Full Text] [Related]
17. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial. Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280 [TBL] [Abstract][Full Text] [Related]
18. Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials). Halligan S; Dadswell E; Wooldrage K; Wardle J; von Wagner C; Lilford R; Yao GL; Zhu S; Atkin W Health Technol Assess; 2015 Jul; 19(54):1-134. PubMed ID: 26198205 [TBL] [Abstract][Full Text] [Related]
19. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161 [TBL] [Abstract][Full Text] [Related]
20. The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study. Wisse PHA; de Klaver W; van Wifferen F; van Maaren-Meijer FG; van Ingen HE; Meiqari L; Huitink I; Bierkens M; Lemmens M; Greuter MJE; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; Carvalho B; de Wit M; Meijer GA Lancet Oncol; 2024 Mar; 25(3):326-337. PubMed ID: 38346438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]